Evommune, Inc. (EVMN) Free cash flow 2024–2025
Evommune, Inc. (EVMN) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$76.7MFY2025 · since FY2024: -$58.3M → -$76.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$76.7M | -31.6% |
| FY2024 | -$58.3M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More EVMN financial trends
EVMN RevenueEVMN Net incomeEVMN Net marginEVMN Gross profitEVMN Gross marginEVMN Operating incomeEVMN Operating marginEVMN Operating cash flowEVMN Capital expendituresEVMN Return on equityEVMN Stock buybacksEVMN Dividends paidEVMN Total assetsEVMN Total liabilitiesEVMN Shareholders’ equityEVMN overview →